Literature DB >> 7837968

Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients.

J J Wisnieski1, A N Baer, J Christensen, T R Cupps, D N Flagg, J V Jones, P L Katzenstein, E R McFadden, J J McMillen, M A Pick.   

Abstract

We identify and describe clinical findings in hypocomplementemic urticarial vasculitis syndrome (HUVS), an uncommon to rare illness related to systemic lupus erythematosus (SLE). A patient with recurrent, idiopathic urticaria-like lesions was diagnosed as having HUVS if a lesional biopsy showed leukocytoclastic vasculitis, the serum C1q was markedly decreased, and antibody to C1q was detected in the patient's serum. The clinical characteristics, serologic findings, and outcome of patients who met these criteria were determined from prospective and retrospective data, including hospital and office records, patient interviews, previously banked serum samples, and freshly drawn sera. Eighteen patients with HUVS were identified, and high incidences of angioedema, ocular inflammation, glomerulonephritis, and obstructive pulmonary disease were found. Renal and lung biopsies showed mesangial or membranoproliferative glomerulonephritis and severe pulmonary emphysema without vasculitis. Pulmonary function was measured in 17 patients, 11 of whom had dyspnea. All dyspneic patients had moderate to severe airflow obstruction, which progressed in all 11 and subsequently improved in only 1. Six of these 11 patients died of respiratory failure, 1 underwent lung transplantation, and 3 of the remaining 4 have moderately severe to life-threatening respiratory insufficiency. Treatment did not appear to alter the progression of obstructive lung disease. In contrast, renal insufficiency improved with treatment in 2 of 2 patients. Angioedema, ocular inflammation, obstructive lung disease, and glomerulonephritis appear to be common in HUVS, and lung disease causes substantial morbidity and mortality. The pathogenesis of HUVS may involve humoral autoimmunity, although it is not clear how autoimmunity would participate in development of obstructive lung disease. Cigarette smoking appears to be a risk factor for fatal lung disease in HUVS. All patients with HUVS should be made aware of this possibility and should be advised, encouraged, and helped to avoid tobacco smoke.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7837968     DOI: 10.1097/00005792-199501000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  41 in total

1.  C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury.

Authors:  Dilip Shah; Freddy Romero; Ying Zhu; Michelle Duong; Jianxin Sun; Kenneth Walsh; Ross Summer
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

2.  Inflammatory myositis complicating hypocomplementemic urticarial vasculitis despite on-going immunosuppression.

Authors:  Gary Y J Chew; Paul A Gatenby
Journal:  Clin Rheumatol       Date:  2006-08-30       Impact factor: 2.980

3.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Meningococcal meningitis in a patient with urticarial vasculitis: is there a link?

Authors:  Hana Alachkar; Faieza Qasim; Yasmeen Ahmad; Matthew Helbert
Journal:  J Clin Pathol       Date:  2007-10       Impact factor: 3.411

5.  Hypocomplementemic urticarial vasculitis (HUVS) with precocious emphysema responsive to azathioprine.

Authors:  L Breda; M Nozzi; S Harari; M Del Torto; M Lucantoni; A Scardapane; F Chiarelli
Journal:  J Clin Immunol       Date:  2013-04-25       Impact factor: 8.317

6.  Cigarette smoke-induced reduction of C1q promotes emphysema.

Authors:  Xiaoyi Yuan; Cheng-Yen Chang; Ran You; Ming Shan; Bon Hee Gu; Matthew C Madison; Gretchen Diehl; Sarah Perusich; Li-Zhen Song; Lorraine Cornwell; Roger D Rossen; Rick Wetsel; Rajapakshe Kimal; Cristian Coarfa; Holger K Eltzschig; David B Corry; Farrah Kheradmand
Journal:  JCI Insight       Date:  2019-05-21

Review 7.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 8.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

Review 9.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

10.  Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus.

Authors:  Min Young Her; Joo Yeon Song; Dong Yook Kim
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.